Inventor
GOMTSYAN ARTHUR
US19 patents
⚠️ This page may combine multiple inventors who share the name “GOMTSYAN ARTHUR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
8 patentsUS8772499B2Jul 8, 2014
TRPV3 modulators
ABBVIE INC1 citations51
US8772500B2Jul 8, 2014
TRPV3 modulators
ABBVIE INC1 citations51
US10266532B2Apr 23, 2019
Tricyclic modulators of TNF signaling
ABBVIE INC0 citations47
US8969325B2Mar 3, 2015
TRPV1 antagonists
ABBVIE INC0 citations41
US9156788B2Oct 13, 2015
TRPV3 modulators
ABBVIE INC0 citations40
US8859584B2Oct 14, 2014
TRPV1 antagonists
ABBVIE INC0 citations39
US8796328B2Aug 5, 2014
TRPV1 antagonists
ABBVIE INC0 citations39
US9447051B2Sep 20, 2016
Diaminopyrimidines and uses thereof
ABBVIE INC0 citations38
ABBOTT LAB
7 patentsUS7015233B2Mar 21, 2006
Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
ABBOTT LAB39 citations96
US8026256B2Sep 27, 2011
Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
ABBOTT LAB11 citations84
US7998993B2Aug 16, 2011
TRPV1 antagonists
ABBOTT LAB8 citations83
US7902236B2Mar 8, 2011
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof
ABBOTT LAB7 citations83
US7504520B2Mar 17, 2009
Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof
ABBOTT LAB7 citations73
US6693136B1Feb 17, 2004
Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptors
ABBOTT LAB7 citations68
US7812019B2Oct 12, 2010
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
ABBOTT LAB0 citations51